Education
About Us
Working with TipRanks
Follow Us
Novonesis (NVZMY)
OTHER OTC:NVZMY
Earnings Data
Report Date
May 08, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
0.42Last Year’s EPS
0.54Same Quarter Last Year
Based on 0 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 26, 2025
|% Change Since: 9.81%
|Next Earnings Date:May 08, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted strong organic growth, improved profitability, successful integration, and sustainability achievements. However, challenges in the Human Health segment, particularly in the U.S. and China, and the impact of exiting certain markets were noted. Despite these challenges, the overall outlook for 2025 remains positive.Company Guidance
In the Novonesis Full Year Financial Statement for 2024, the company highlighted several key metrics and strategic achievements. The company reported an 8% organic sales growth for the year, driven by a 6% volume increase and a 2% contribution from pricing. Emerging markets exhibited robust growth with a 12% increase. The company's adjusted EBITDA margin improved to 36.1%, a 2.3 percentage point increase from 2023, supported by cost synergies and operational excellence. Novonesis launched 45 new products and achieved a 30% revenue contribution from innovations in the past five years. The firm also made significant strides in sustainability, with 80%-83% of revenue aligned with the UN's Sustainable Development Goals, and reduced Scope 1 and 2 CO2 emissions by 63% since 2018. Looking ahead, Novonesis projects a 5% to 8% organic sales growth for 2025, with an anticipated EBITDA margin between 37% and 38%.Strong Organic Sales Growth
Novonesis delivered a strong broad-based organic growth of 8% for the year 2024, driven by a 6% volume increase and a 2% contribution from pricing. Emerging markets were particularly strong, delivering 12% growth.
Improved Profitability
The strong sales growth coupled with cost synergies and operational excellence led to a 36.1% pro forma adjusted EBITDA margin for the year, an increase of 2.3 percentage points compared to 2023.
Successful Integration and Cost Synergy Achievement
Novonesis has achieved an 80% run rate of the three-year cost synergy program in the first year. The company is on track to realize a €200 million run rate in revenue synergy program.
Sustainability Achievements
80% – 83% of revenue is aligned with six of the United Nations Sustainable Development Goals. Since 2018, Scope 1 and 2 CO2 emissions have been reduced by 63%.
New Product Launches
In 2024, Novonesis launched 45 new products across industries and geographies, solidifying their innovation leadership in biosolutions.
Positive Outlook for 2025
For 2025, Novonesis expects continued strong growth performance of 5% to 8%, with a 37% to 38% outlook for the adjusted EBITDA margin.
---
NVZMY Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
NVZMY Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 26, 2025 | $56.66 | $59.93 | +5.77% |
| Nov 07, 2024 | $58.36 | $61.08 | +4.66% |
| Aug 27, 2024 | $66.93 | $67.52 | +0.88% |
| May 03, 2024 | $55.31 | $58.99 | +6.65% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Novonesis (NVZMY) report earnings?
Novonesis (NVZMY) is schdueled to report earning on May 08, 2025, TBA Not Confirmed.
What is Novonesis (NVZMY) earnings time?
Novonesis (NVZMY) earnings time is at May 08, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is NVZMY EPS forecast?
NVZMY EPS forecast for the fiscal quarter 2025 (Q1) is 0.42.
---